These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7325636)

  • 21. Should daptomycin-rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?
    Stein C; Makarewicz O; Forstner C; Weis S; Hagel S; Löffler B; Pletz MW
    Infection; 2016 Aug; 44(4):499-504. PubMed ID: 26797915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain.
    Peacock JE; Moorman DR; Wenzel RP; Mandell GL
    J Infect Dis; 1981 Dec; 144(6):575-82. PubMed ID: 6977003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents.
    Khurana S; Mathur P; Malhotra R
    J Glob Antimicrob Resist; 2019 Jun; 17():98-102. PubMed ID: 30389637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of minocycline and rifampin against staphylococci.
    Segreti J; Gvazdinskas LC; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3):253-5. PubMed ID: 2791487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causes and Implications of the Disappearance of Rifampin Resistance in a Rat Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis.
    Brinkman CL; Tyner HL; Schmidt-Malan SM; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4481-8. PubMed ID: 25987614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of clindamycin in combination with rifampicin on clindamycin-susceptible and clindamycin-resistant Staphylococcus aureus.
    Watanakunakorn C
    J Antimicrob Chemother; 1985 Sep; 16(3):335-9. PubMed ID: 4055542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between vancomycin and rifampin against Staphylococcus aureus.
    Watanakunakorn C; Guerriero JC
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1089-91. PubMed ID: 7271276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
    O'Neill AJ; Cove JH; Chopra I
    J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
    Johnston BL; Kwok RY; Mulligan ME
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of antibiotic treatment of implant-associated
    Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
    Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.
    Tuazon CU; Lin MY; Sheagren JN
    Antimicrob Agents Chemother; 1978 May; 13(5):759-61. PubMed ID: 666300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
    Lorian V; Atkinson B; Kim Y
    Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
    Liu Y; Cui J; Wang R; Wang X; Drlica K; Zhao X
    J Antimicrob Chemother; 2005 Dec; 56(6):1172-5. PubMed ID: 16207765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.
    Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK
    Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characteristics and virulence gene profiles of Staphylococcus aureus isolates in Hainan, China.
    Li X; Huang T; Xu K; Li C; Li Y
    BMC Infect Dis; 2019 Oct; 19(1):873. PubMed ID: 31640587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
    Eng RH; Smith SM; Buccini FJ; Cherubin CE
    J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
    Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
    Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.